Pediatric warfarin practice and pharmacogenetic testing

被引：8
|
作者：
Thornburg, Courtney D. [1 ]
Jones, Emma [2 ]
Bomgaars, Lisa [2 ]
Gage, Brian F. [3 ]
机构：
[1] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA
[2] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[3] Washington Univ, Dept Med, St Louis, MO USA
来源：
THROMBOSIS RESEARCH | 2010年 / 126卷 / 02期
关键词：
Children; Genetic testing; Anticoagulant therapy; MOLECULAR-WEIGHT HEPARIN; RANDOMIZED CONTROLLED-TRIAL; ORAL ANTICOAGULATION; ANTITHROMBOTIC THERAPY; CHILDREN; CYP2C9; THROMBOEMBOLISM; POLYMORPHISM; INITIATION;
D O I：
10.1016/j.thromres.2009.12.022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E144 / E146
页数：3
相关论文
共 50 条
  • [41] Validation and Comparison of Pharmacogenetics-Based Warfarin Dosing Algorithms for Application of Pharmacogenetic Testing
    Roper, Nitin
    Storer, Barry
    Bona, Robert
    Fang, Min
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (03): : 283 - 291
  • [42] Characterization of 107 Genomic DNA Reference Materials for Warfarin-Sensitivity Pharmacogenetic Testing
    Zehnbauer, B.
    Pratt, V. M.
    Baak, R.
    Babic, N.
    Buller, A.
    El-Badry, A.
    Mandal, S.
    McKinney, J.
    Muralidharan, K.
    Noll, L.
    Sander, T.
    Telatar, M.
    Toji, L.
    Vairavan, A.
    Yeo, K.
    Zeller, M.
    Kalman, L.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 626 - 626
  • [43] Which of Algorithms of Warfarin Dosing Based on Results of Pharmacogenetic Testing is Suitable for Patients in Russia?
    Sychev, D. A.
    Antonov, I. M.
    Kropacheva, E. S.
    Panchenko, E. P.
    [J]. KARDIOLOGIYA, 2010, 50 (04) : 35 - 37
  • [44] Using Pharmacogenetic Testing to Tailor Warfarin Therapy: The Singapore Experience and What the Future Holds
    Chang, Grace Shu-wen
    Tan, Doreen Su-Yin
    [J]. EUROPEAN CARDIOLOGY REVIEW, 2020, 15
  • [45] Confirmation practice in pharmacogenetic testing; how good is good enough?
    Lunenburg, Carin A. T. C.
    Guchelaar, Henk-Jan
    van Schaik, Ron H. N.
    Neumaier, Michael
    Swen, Jesse J.
    [J]. CLINICA CHIMICA ACTA, 2019, 490 : 77 - 80
  • [46] Use of PHQ-9 and pharmacogenetic testing in clinical practice
    Kierce, Erica D.
    Vanderhoef, Dawn M.
    Connors, Laurie M.
    [J]. JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2019, 31 (09) : 497 - 501
  • [47] Clinical implications of pharmacogenetic and microarray testing for advanced practice nurses
    Brennan, Kathleen S.
    [J]. JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2015, 27 (05) : 246 - 255
  • [48] Systematic Review of Pharmacogenetic Warfarin Dosing
    van Schie, Rianne M. F.
    Jorgensen, Andrea L.
    de Boer, Anthonius
    Maitland-van der Zee, Anke-Hilse
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 (10) : 1171 - 1171
  • [49] Understanding the pharmacogenetic approach to warfarin dosing
    Glurich, Ingrid
    Burmester, James K.
    Caldwell, Michael D.
    [J]. HEART FAILURE REVIEWS, 2010, 15 (03) : 239 - 248
  • [50] Pharmacogenetic determinants of warfarin in the Indian population
    Naushad, Shaik Mohammad
    Kutala, Vijay Kumar
    Hussain, Tajamul
    Alrokayan, Salman A.
    [J]. PHARMACOLOGICAL REPORTS, 2021, 73 (05) : 1396 - 1404
12345